In-vitro and Companion Diagnostics Industry - 2010 Yearbook

Summary

GBI Research’s report, “In-vitro and Companion Diagnostics Industry- 2010 Yearbook” provides key data, information and analysis on the global invitro diagnostic and companion diagnostics market. The report provides a market landscape, competitive landscape and market trends information on the following market categories: clinical chemistry, immunochemistry, hematology, histology and cytology, microbiology, infectious immunology, genetic testing and companion diagnostics. The report provides comprehensive information on the key trends affecting the aforementioned categories, and key analytical content on the market dynamics. The report also reviews the latest, advances in in-vitro diagnostics technology. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

Its scope includes:
- Market revenue data from 2002 to 2009. Forecast revenue data to 2016. Company shares data for 2009.
- Market size and company share data for six diagnostic imaging market categories: clinical chemistry, immunochemistry, hematology, histology and cytology, microbiology, infectious immunology, genetic testing and companion diagnostics.
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain and Japan.
- Qualitative analysis of the key market trends, and market drivers and restraints, by each category within the diagnostic imaging market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
- Key players covered include F.Hoffman-La Roche, Abbott Laboratories, bioMerieux, Beckman Coulter, Qiagen, Dako Denmark A/S, Siemens Medical Solutions.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:
- Develop business strategies by understanding the trends and developments that are driving the diagnostic imaging market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipelines.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products most likely to ensure a robust return.
- What’s the next big thing in the diagnostic imaging market landscape? Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global diagnostic imaging market and the factors shaping it.

Table Of Contents

1 Table of Contents 4
1.1 List of Tables 8
1.2 List of Figures 10
2 Global IVD and CDx Market: Introduction and Overview 12
2.1 In-vitro and Companion diagnostics 12
2.1.1 Overview 12
2.2 GBI Research Report Guidance 13
3 Global IVD and CDx Market: Market Characterization 14
3.1 Global IVD and CDx Market, Revenues ($m), 2002-2009 14
3.2 Global IVD and CDx Market, Revenue Forecasts ($m), 2009-2016 16
3.3 Global IVD and CDx Market, Key Company Shares (%), 2009 18
3.4 Global IVD and CDx Market: Key Market Trends 19
3.4.1 Entry of Diagnostic Imaging Players Into In Vitro Diagnostics Market has Set the Stage for New Technologies to be Developed by Marrying the Two Disciplines 19
3.4.2 Large Number of Private Equity/Venture Capital (PE/VC) Investments and Collaborations in the IVD Sector will Fuel Innovation 20
3.4.3 Consolidation of Laboratories across the World 20
3.5 Global IVD and CDx Market: Key Technology Trends 21
3.5.1 Emerging Technologies for Cutting Laboratory Costs 21
3.5.2 New Technologies Improve Speed and Accuracy 22
3.6 Global IVD and CDx Market: Market Drivers 23
3.6.1 Economic Market Drivers 23
3.6.2 Technology Market Drivers 25
3.6.3 Regulatory Market Drivers 25
3.6.4 Social Market Drivers 26
3.7 Global IVD and CDx Market: Market Restraints 26
3.7.1 Economic Market Restraints 26
3.7.2 Social Market Restraints 27
4 Global IVD and CDx Market: Market Category Analysis and Forecasts 28
4.1 Clinical Chemistry Market: Market Characterization 28
4.1.1 Global Clinical Chemistry Market, Revenues ($m), 2002-2009 28
4.1.2 Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009-2016 30
4.1.3 Global Clinical Chemistry Market, Key Company Shares (%), 2009 32
4.1.4 Clinical Chemistry Market: Market Drivers 33
4.1.5 Clinical Chemistry Market: Market Restraints 34
4.2 Immuno Chemistry Market: Market Characterization 36
4.2.1 Global Immuno Chemistry Market, Revenues ($m), 2002-2009 36
4.2.2 Global Immuno Chemistry Market, Revenue Forecasts ($m), 2009-2016 38
4.2.3 Global Immuno Chemistry Market, Key Company Shares (%), 2009 40
4.2.4 Immuno Chemistry Market: Market Drivers 42
4.2.5 Immuno Chemistry Market: Market Restraints 44
4.3 Hematology Market: Market Characterization 45
4.3.1 Global Hematology Market, Revenues ($m), 2002-2009 45
4.3.2 Global Hematology Market, Revenue Forecasts ($m), 2009-2016 47
4.3.3 Global Hematology Market, Key Company Shares (%), 2009 49
4.3.4 Hematology Market: Market Drivers 50
4.3.5 Hematology Market: Market Restraints 51
4.4 Histology and Cytology Market: Market Characterization 52
4.4.1 Global Histology and Cytology Market, Revenue ($m), 2002-2009 52
4.4.2 Global Histology and Cytology Market, Revenue Forecasts ($m), 2009-2016 53
4.4.3 Global Histology and Cytology Market, Key Company Shares (%), 2009 54
4.4.4 Histology and Cytology Market: Market Drivers 55
4.4.5 Histology and Cytology Market: Market Restraints 56
4.5 Microbiology Culture Market: Market Characterization 57
4.5.1 Global Microbiology Culture Market, Revenues ($m), 2002-2009 57
4.5.2 Global Microbiology Culture Market, Revenue Forecasts ($m), 2009-2016 59
4.5.3 Global Microbiology Culture Market, Key Company Shares (%), 2009 61
4.5.4 Global Microbiology Culture Market: Market Drivers 62
4.5.5 Global Microbiology Culture Market: Market Restraints 63
4.6 Infectious Immunology Market: Market Characterization 64
4.6.1 Global Infectious Immunology Market, Revenues ($m), 2002-2009 64
4.6.2 Global Infectious Immunology Market, Revenue Forecasts ($m), 2009-2016 65
4.6.3 Global Infectious Immunology Market, Key Company Shares (%), 2009 66
4.6.4 Global Infectious Immunology Market: Market Drivers 67
4.6.5 Global Infectious Immunology Market: Market Restraints 68
4.7 Genetic Testing Market: Market Characterization 69
4.7.1 Global Genetic Testing Market, Revenues ($m), 2002-2009 69
4.7.2 Global Genetic Testing Market, Revenue Forecasts ($m), 2009-2016 70
4.7.3 Global Genetic Testing Market, Key Company Shares (%), 2009 71
4.7.4 Global Genetic Testing Market: Market Drivers 72
4.7.5 Global Genetic Testing Market: Market Restraints 73
4.8 Global Companion Diagnostics Market: Market Characterization 74
4.8.1 Introduction 74
4.8.2 Selected Companion Diagnostic Assays/Kits 77
4.8.3 Applications of Companion Diagnostics 80
4.8.4 Global Companion Diagnostics Market, Revenue Forecasts ($m), 2009-2016 82
4.8.5 Global Companion Diagnostics Market, Oncology, Revenue Forecasts ($m), 2009-2016 83
4.8.6 Global Companion Diagnostics Market, Infectious Diseases, Revenue Forecasts ($m), 2009-2016 85
4.8.7 Global Companion Diagnostics Market, Cardiovascular Diseases, Revenue Forecasts ($m), 2009-2016 87
4.8.8 Global Companion Diagnostics Market, 2010 88
4.8.9 Global Companion Diagnostics Market: Market Drivers 89
4.8.10 Global Companion Diagnostics Market: Market Restraints 89
5 Global IVD and CDx Market: Country Analysis and Forecasts 91
5.1 Global IVD Market: Geographic Trends Analysis 91
5.2 Market Characterization, the US, 2002-2016 92
5.2.1 The US IVD and CDx Market, Revenues ($m), 2002-2009 92
5.2.2 The US IVD and CDx Market, Revenues ($m), 2009-2016 94
5.2.3 The US IVD and CDx Market, Market Drivers 95
5.2.4 The US IVD and CDx Market, Market Restraints 95
5.3 Market Characterization, Europe, 2002-2016 96
5.3.1 The UK IVD and CDx Market 96
5.3.2 The UK IVD and CDx Market, Revenues ($m), 2009-2016 97
5.3.3 Germany IVD and CDx Market, Revenues ($m), 2002-2009 99
5.3.4 Germany IVD and CDx Market, Revenues ($m), 2009-2016 101
5.3.5 France IVD and CDx Market, Revenues ($m), 2002-2009 103
5.3.6 France IVD and CDx Market, Revenues ($m), 2009-2016 105
5.3.7 Italy IVD and CDx Market, Revenues ($m), 2002-2009 107
5.3.8 Italy IVD and CDx Market, Revenues ($m), 2009 - 2016 109
5.3.9 Spain IVD and CDx Market, Revenues ($m), 2002-2009 111
5.3.10 Spain IVD and CDx Market, Revenues ($m), 2009-2016 113
5.3.11 Europe IVD and CDx Market, Market Drivers 114
5.3.12 Europe IVD and CDx Market, Market Restraints 115
5.4 Market Characterization, Japan, 2002-2016 116
5.4.1 Japan IVD and CDx Market, Revenues ($m), 2002-2009 116
5.4.2 Japan IVD and CDx Market, Revenues ($m), 2009-2016 118
5.4.3 Japan IVD and CDx Market, Market Drivers 119
5.4.4 Japan IVD and CDx Market, Market Restraints 120
6 Global IVD and CDx Market: Strategic Competitive Assessment 121
6.1 Key Market Participants 121
6.1.1 F. Hoffmann-La Roche Ltd 121
6.1.2 Siemens Medical Solutions USA, Inc. 125
6.1.3 Abbott Laboratories 127
6.1.4 Beckman Coulter, Inc. 130
6.1.5 bioMerieux Sa 133
6.1.6 Ortho-Clinical Diagnostics 135
6.1.7 Becton, Dickinson and Company 136
6.1.8 Bio-Rad Laboratories, Inc. 138
6.1.9 Roche Diagnostics 138
6.1.10 Epigenomics AG 140
6.1.11 Qiagen N.V 141
6.1.12 Dako Denmark A/S 142
6.1.13 Celera Corporation 143
7 Global IVD and CDx Market: Product Pipeline Analysis 145
7.1 Pipeline Products Analysis by Category 145
7.1.1 Pipeline Products Analysis: Immuno Chemistry Market 146
7.1.2 Pipeline Products Analysis: Infectious Immunology 148
7.1.3 Pipeline Products Analysis: Companion Diagnostics 149
7.2 Key Pipeline Products Currently Undergoing Development 151
7.2.1 Clinical Chemistry Pipeline Products 151
7.2.2 Genetic Testing 151
7.2.3 Hematology 152
7.2.4 Immunochemistry 152
7.2.5 Infectious Immunology 153
7.2.6 Microbiology Culture 154
7.2.7 Histology and Cytology 155
7.2.8 Companion Diagnostics 155
8 Global IVD and CDx Market: Consolidation Landscape 156
8.1 Deals by Type, 2006-2010 156
8.2 Key MandA Deals, 2009 and 2010 157
8.2.1 Merck Completes Acquisition of Millipore 157
8.2.2 Laboratory Corporation of America Completes Acquisition of Genzyme Genetics From Genzyme 157
8.2.3 GE Healthcare Completes Acquisition of Clarient 158
8.2.4 Agilent Technologies Receives Shareholders Approval To Acquire Varian 158
8.2.5 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 159
8.2.6 MDS Receives Shareholder Approval To Sell MDS Analytical Technologies To Danaher 159
9 Appendix 165
9.1 Market Definitions 165
9.1.1 Clinical Chemistry 165
9.1.2 Immunochemistry Test Reagents 166
9.1.3 Hematology 167
9.1.4 Histology and Cytology 168
9.1.5 Microbiology Culture 169
9.1.6 Infectious Immunology 169
9.1.7 Genetic Testing 170
9.1.8 Acquired Gene or Chromosome Alterations 170
9.1.9 Companion Diagnostics 170
9.2 List of Abbreviations 171
9.3 Research Methodology 172
9.3.1 Secondary Research 172
9.3.2 Primary Research 172
9.3.3 Models 173
9.3.4 Forecasts 173
9.3.5 Expert Panels 173
9.4 Contact Us 174
9.5 Disclaimer 174
9.6 Sources 174

1.1 List of Tables

Table 1: IVD and CDx Market, Global, Revenue ($m), 2002-2009 14
Table 2: IVD and CDx Market, Global, Revenue ($m), 2009-2016 16
Table 3: IVD Market, Global, Company Revenues ($m), 2009 18
Table 4: Clinical Chemistry Market, Global, Revenues ($m), 2002-2009 28
Table 5: Clinical Chemistry Market, Global, Revenue ($m), 2009-2016 30
Table 6: Clinical Chemistry Market, Global, Company Revenues ($m), 2009 32
Table 7: Clinical Chemistry Market, Comparison of Top Seven Countries by Revenue, 2002-2016 33
Table 8: Immuno Chemistry Market, Global, Revenues ($m), 2002-2009 36
Table 9: Immuno Chemistry Market, Global, Revenue ($m), 2009-2016 38
Table 10: Immuno Chemistry Market, Global, Company Revenues ($m), 2009 40
Table 11: Immuno Chemistry Market, Comparison of Top Seven Countries by Revenue, 2002-2016 42
Table 12: Hematology Market, Global, Revenue ($m), 2002-2009 45
Table 13: Hematology Market, Global, Revenue ($m), 2009-2016 47
Table 14: Hematology Market, Global, Company Revenues ($m), 2009 49
Table 15: Hematology Market, Comparison of Top Seven Countries by Revenue, 2002-2016 50
Table 16: Histology and Cytology Market, Global, Revenue ($m), 2002-2009 52
Table 17: Histology and Cytology Market, Global, Revenue ($m), 2009-2016 53
Table 18: Histology and Cytology Market, Global, Company Revenues ($m), 2009 54
Table 19: Histology and Cytology Market, Comparison of Top Seven Countries by Revenue, 2002-2016 55
Table 20: Microbiology Culture Market, Global, Revenue ($m), 2002-2009 57
Table 21: Microbiology Culture Market, Global, Revenue ($m), 2009-2016 59
Table 22: Microbiology Culture Market, Global, Company Revenues ($m), 2009 61
Table 23: Microbiology Culture Market, Comparison of Top Seven Countries by Revenue ($m), 2002-2016 62
Table 24: Infectious Immunology Market, Global, Revenue ($m), 2002-2009 64
Table 25: Infectious Immunology Market, Global, Revenue ($m), 2009-2016 65
Table 26: Infectious Immunology Market, Global, Company Revenues ($m), 2009 66
Table 27: Infectious Immunology Market, Comparison of Top Seven Countries by Revenue ($m), 2002-2016 67
Table 28: Genetic Testing Market, Global, Revenue ($m), 2002-2009 69
Table 29: Genetic Testing Market, Global, Revenue ($m), 2009-2016 70
Table 30: Global Genetic Testing Market, Global, Company Revenues ($m), 2009 71
Table 31: Genetic Testing Market, Comparison of Top Seven Countries by Revenue ($m), 2002-2016 72
Table 32: Companion Diagnostics, List of Selected Companion Diagnostics and Personalized Therapeutics, 2010* 76
Table 33: Companion Diagnostics Market, Oncology, Global, Revenues ($m), 2009-2016 83
Table 34: Global Companion Diagnostics Market, Infectious Diseases, 2010 86
Table 35: Companion Diagnostics Market, Cardiovascular, the US, Revenues ($m), 2009-2016 87
Table 36: IVD and CDx Market, the US, Revenue ($m), 2002-2009 92
Table 37: IVD and Companion Diagnostics Market, the US, Revenue ($m), 2009-2016 94
Table 38: IVD and CDx Market, The UK, Revenue ($m), 2002-2009 96
Table 39: IVD Market, The UK, Revenue ($m), 2009-2016 97
Table 40: IVD Market, Germany, Revenues ($m), 2002-2009 99
Table 41: IVD Market, Germany, Revenue ($m), 2009-2016 101
Table 42: IVD Market, France, Revenue ($m), 2002-2009 103
Table 43: IVD Market, France, Revenue ($m), 2009-2016 105
Table 44: IVD and CDx Market, Italy, Revenue ($m), 2002-2009 107
Table 45: IVD Market, Italy, Revenue ($m), 2009-2016 109
Table 46: IVD Market, Spain, Revenue ($m), 2002-2009 111
Table 47: IVD and CDx Market, Spain, Revenue ($m), 2009-2016 113
Table 48: IVD Market, Japan, Revenue ($m), 2002-2009 116
Table 49: IVD and CDx Market, Japan, Revenue ($m), 2009-2016 118
Table 50: Roche’s Merger and Acquisitions, IVD Market, 2007-2009 122
Table 51: Roche IVD Pipeline Product Portfolio 123
Table 52: Siemen’s Merger and Acquisitions, IVD Market, 2007-2009 125
Table 53: Siemens Medical Solutions IVD Pipeline Product Portfolio 126
Table 54: Abbott Laboratories’ Mergers and Acquisitions, IVD Market, 2007-2009 128
Table 55: Abbott Laboratories’ Licensing Deals, Companion Diagnostics Market, 2004-2010 128
Table 56: Abbott Laboratories IVD Pipeline Products 129
Table 57: Abbott Diagnostics, Companion Diagnostics Pipeline Portfolio 130
Table 58: Beckman Coulter’s Mergers and Acquisitions, IVD Market, 2007-2009 131
Table 59: Beckman Coulter, Inc. IVD Pipeline Products 132
Table 60: bioMerieux’s Mergers and Acquisitions, IVD Market, 2007-2009 134
Table 61: bioMerieux’s Mergers and Acquisitions, Companion Diagnostics Market, 2004-2010 134
Table 62: bioMerieux Sa IVD Pipeline Products 135
Table 63: bioMerieux, Inc., Companion Diagnostics Pipeline Portfolio 135
Table 64: Ortho-Clinical Diagnostics, IVD Pipeline Products 136
Table 65: Becton Dickinson, Mergers and Acquisitions, IVD Market, 2007-2009 137
Table 66: Becton, Dickinson Inc. IVD Pipeline Portfolio 137
Table 67: Bio-Rad Laboratories, Merger and Acquisitions, IVD Market, 2007-2009 138
Table 68: Roche Diagnostics, Licensing Deals, Companion Diagnostics Market, 2004-2010 139
Table 69: Roche Diagnostics, Companion Diagnostics Pipeline Portfolio, 2010 140
Table 70: Epigenomics, Companion Diagnostics, Licensing Deals, 2004-2010 141
Table 71: Epigenomics, Companion Diagnostics Pipeline Portfolio, 2010 141
Table 72: Qiagen N.V, Licensing Deals, Companion Diagnostics Market, 2004-2010 142
Table 73: Qiagen, Companion Diagnostics Pipeline Portfolio, 2010 142
Table 74: Dako Denmark A/S, Licensing Deals, Companion Diagnostics Market, 2004-2010 143
Table 75: Dako Denmark A/S, Companion Diagnostics Pipeline Portfolio, 2010 143
Table 76: Celera, Licensing Deals, 2004-2010 144
Table 77: Celera, Companion Diagnostics Pipeline Portfolio 144
Table 78: IVD and CDx Market, Global, Pipeline Products by Category, 2010 145
Table 79: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2010 146
Table 80: Infectious Immunology Market, Global, 2010 148
Table 81: Deals By Type, Global IVD and CDx Market, 2006-2010 156
Table 82: Key Deals, Mergers and Acquisitions, Global IVD Market, 2010 160
Table 83: Key Deals, Mergers and Acquisitions, Global IVD Market, 2009 162

1.2 List of Figures

Figure 1: IVD and CDx Market, Global, Revenue ($m), 2002-2009 14
Figure 2: IVD and CDx Market, Global, Revenue ($m), 2009-2016 16
Figure 3: IVD and CDx Market, Global, Company Share (%), 2009 18
Figure 4: Global Laboratory Consolidation Landscape, 2005-2009 20
Figure 5: List of Retail Clinics in the US and Diagnostic IVD Tests Offered 24
Figure 6: Clinical Chemistry Market, Global, Revenues ($m), 2002-2009 28
Figure 7: Clinical Chemistry Market, Global, Revenue ($m), 2009-2016 30
Figure 8: Clinical Chemistry Market, Global, Company Share (%), 2009 32
Figure 9: Clinical Chemistry Market, Comparison of Top Seven Countries By Revenue, 2002-2016 33
Figure 10: Immuno Chemistry Market, Global, Revenues ($m), 2002-2009 36
Figure 11: Immuno Chemistry Market, Global, Revenue ($m), 2009-2016 38
Figure 12: Immuno Chemistry Market, Global, Company Share (%), 2009 40
Figure 13: Immuno Chemistry Market, Comparison of Top Seven Countries By Revenue, 2002-2016 42
Figure 14: Hematology Market, Global, Revenues ($m), 2002-2009 45
Figure 15: Hematology Market, Global, Revenue ($m), 2009-2016 47
Figure 16: Hematology Market, Global, Company Share (%), 2009 49
Figure 17: Haematology Market, Comparison of Top Seven Countries By Revenue, 2002-2016 50
Figure 18: Histology and Cytology Market, Global, Revenue ($m), 2002-2009 52
Figure 19: Histology and Cytology Market, Global, Revenue ($m), 2009-2016 53
Figure 20: Histology and Cytology Market, Global, Company Share (%), 2009 54
Figure 21: Histology and Cytology Market, Comparison of Top Seven Countries By Revenue, 2002-2016 55
Figure 22: Microbiology Culture Market, Global, Revenue ($m), 2002-2009 57
Figure 23: Microbiology Culture Market, Global, Revenue ($m), 2009-2016 59
Figure 24: Microbiology Market, Global, Company Share (%), 2009 61
Figure 25: Microbiology Culture Market, Comparison of Top Seven Countries By Revenue, 2002-2016 62
Figure 26: Infectious Immunology Market, Global, Revenue ($m), 2002-2009 64
Figure 27: Infectious Immunology Market, Global, Revenue ($m), 2009-2016 65
Figure 28: Infectious Immunology Market, Global, Company Share (%), 2009 66
Figure 29: Infectious Immunology Culture Market, Comparison of Top Seven Countries By Revenue, 2002-2016 67
Figure 30: Genetic Testing Market, Global, Revenue ($m), 2002-2009 69
Figure 31: Genetic Testing Market, Global, Revenue ($m), 2009-2016 70
Figure 32: Global Genetic Testing Market, Global, Company Share (%), 2009 71
Figure 33: Genetic Testing Market, Comparison of Top Seven Countries By Revenue, 2002-2016 72
Figure 34: Companion Diagnostics, Adoption Trend, 2010 75
Figure 35: Applications of Companion Diagnostics, 2010 80
Figure 36: Companion Diagnostics Market, Oncology, Global, Revenue ($m), 2009-2016 83
Figure 37: Companion Diagnostics Market, Herceptin Prescription Pattern, 2010 84
Figure 38: Global Companion Diagnostics Market, Infectious Diseases, 2010 85
Figure 39: Global Companion Diagnostics Market, Infectious Diseases, 2010 86
Figure 40: Companion Diagnostics Market, Cardiovascular Diseases, the US, Revenues ($m), 2010 87
Figure 41: Companion Diagnostics Market, Global, 2010 88
Figure 42: IVD Market, Global, Geographic Trends Analysis 91
Figure 43: IVD and CDx Market, the US, Revenue ($m), 2002-2009 92
Figure 44: IVD and CDx Market, the US, Revenue ($m), 2009-2016 94
Figure 45: IVD and CDx Market, The UK, Revenue ($m), 2002-2009 96
Figure 46: IVD and CDx Market, The UK, Revenue ($m), 2009-2016 97
Figure 47: IVD and CDx Market, Germany, Revenue ($m), 2002-2009 99
Figure 48: IVD and CDx Market, Germany, Revenue ($m), 2009-2016 101
Figure 49: IVD and CDx Market, France, Revenue ($m), 2002-2009 103
Figure 50: IVD and CDx Market, France, Revenue ($m), 2009-2016 105
Figure 51: IVD Market, Italy, Revenue ($m), 2002-2009 107
Figure 52: IVD and CDx Market, Italy, Revenue ($m), 2009-2016 109
Figure 53: IVD and CDx Market, Spain, Revenue ($m), 2002-2009 111
Figure 54: IVD and CDx Market, Spain, Revenue ($m), 2009-2016 113
Figure 55: IVD and CDx Market, Japan, Revenue ($m), 2002-2009 116
Figure 56: IVD and CDx Market, Japan, Revenue ($m), 2009-2016 118
Figure 57: IVD and CDx Market, Global, Pipeline Products Analysis by Category, 2010 145
Figure 58: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2010 146
Figure 59: Infectious Immunology Market, Global, Pipeline Products Analysis, By Segment, 2010 148
Figure 60: Companion Diagnostics Market, Global, Pipeline Products Analysis, By Therapy Area, 2010 149
Figure 61: Companion Diagnostics Market, Global, Pipeline Products Analysis, Oncology, By Indication, 2010 150
Figure 62: Companion Diagnostics Market, Global, Pipeline Products Analysis, By Phase, 2010 150
Figure 63: Deals By Type, Global IVD and CDx Market, 2006-2010 156

Companies Mentioned
F. Hoffmann-La Roche Ltd
Siemens Medical Solutions USA, Inc.
Abbott Laboratories
Beckman Coulter, Inc.
bioMerieux Sa
Ortho-Clinical Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Roche Diagnostics
Epigenomics AG
Qiagen N.V
Dako Denmark A/S
Celera Corporation

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.